Chesapeake IRB Announces Acquisition of Goodwyn IRB
Combined Assets Expand Expertise and Reach
Chesapeake IRB, announced it has completed the acquisition of Goodwyn IRB.
Goodwyn IRB, headquartered in Cincinnati, Ohio, and Chesapeake IRB, headquartered in Columbia, Maryland are providers of federally mandated institutional review board (“IRB”) services to pharmaceutical, biotech and medical device companies, universities, academic medical centers, hospital systems, governmental entities and others required to use IRB services to assure the protection of rights and the welfare of human subjects participating in research.
Felix Gyi, Founder and CEO of Chesapeake IRB, said, “We are excited to acquire Goodwyn IRB. Their operational expertise and commitment to human protection mirrors our own and will be an asset as we continue to build Chesapeake’s market presence as a leading independent IRB.”
Ellen Kelso, Founder and CEO of Goodwyn IRB, said “Goodwyn IRB is very pleased to be owned by Chesapeake IRB. We will share best practices across the firms while continuing to offer exceptional institutional review board services and human protection to our clients. They will now be able to utilize Chesapeake’s Center for IRB Intelligence (CIRBI) and have real time 24x7 access to all study documents.”
Elyse Summers, President and CEO, Association for the Accreditation of Human Research Protection Programs, commented “AAHRPP is delighted that two AAHRPP accredited, highly respected, independent IRBs have found the common ground of accreditation as a leverage point to create an enhanced organization.”
Goulston & Storrs served as counsel to Chesapeake IRB. Vorys served as counsel to Goodwyn IRB. Madison Capital Funding LLC provided financing to support the transaction.
For questions regarding Chesapeake IRB or Goodwyn IRB please contact:
Ruth Boulter – Vice President Business Development, Chesapeake IRB (609) 731-8786
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
